Clinical trial
Influenza Vaccine in Lung Transplant Patients
NCT00205270 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00205270 |
|---|---|
| Title | Influenza Vaccine in Lung Transplant Patients |
| Official title | Antibody Responses to Influenza Vaccine in Pre- and Post-lung Transplant Patients |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Influenza vaccine |
| Enrollment | 126 |
| Start date | Dec 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 23, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: